Study Links Antidepressants to Faster Cognitive Decline in Dementia, But Experts Urge Caution
A Swedish study found a correlation between antidepressant use and faster cognitive decline in dementia patients, but experts caution against overreacting due to study limitations and contradictory findings showing slower decline than average in treated patients.
Study Links Antidepressants to Faster Cognitive Decline in Dementia, But Experts Urge Caution
A Swedish study found a correlation between antidepressant use and faster cognitive decline in dementia patients, but experts caution against overreacting due to study limitations and contradictory findings showing slower decline than average in treated patients.
Progress
56% Bias Score
GLP-1 RA Drugs Show Promise, but Limitations Remain
A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...
GLP-1 RA Drugs Show Promise, but Limitations Remain
A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...
Progress
44% Bias Score
Diabetes Drugs Linked to Reduced Risk of Mental Health Issues
A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...
Diabetes Drugs Linked to Reduced Risk of Mental Health Issues
A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...
Progress
24% Bias Score
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Progress
52% Bias Score
GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions
A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...
GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions
A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...
Progress
44% Bias Score